reference/4026623

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4026623

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2045-2322
issueIdentifier	1
pageRange	21194-
publicationName	Scientific Reports
startingPage	21194
bibliographicCitation	Takahashi R, Ijichi H, Sano M, Miyabayashi K, Mohri D, Kim J, Kimura G, Nakatsuka T, Fujiwara H, Yamamoto K, Kudo Y, Tanaka Y, Tateishi K, Nakai Y, Morishita Y, Soma K, Takeda N, Moses HL, Isayama H, Koike K. Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. Scientific Reports. 2020 Dec 03;10(1):21194. doi: 10.1038/s41598-020-78320-3.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31d35b290e6e54593391e7a3d7851b2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2379-7986 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fef702deb36b17821fcd33a6a8b1da0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91e07920ee982f955edb88a99998dd14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65e7a4aa7ba419df25f4cb6033966c5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ba7484409111f55855f8472e76a490f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e0c068bbf793d42899b30683396b6e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e22ab62e01318898e9d3c1f3e05ede4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5727-5385 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcdc986e43aeb3705fc3cda4a9cfc416 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_418885bafb641a7d679f7ba466af512a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_315932e9004e88718af9f7b1eca969d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7ee04c700e3961dc3df567071d07c6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c93b65e25ae2428e3c52507cbebafdae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750de570bb7d230263038fe6494b6f4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38f6817d76569f74967a53fbe0ba1daa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bb125eb9093395ea2be87209ae3a2fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f54d500a3cb3be5c5e5cffc5eb24906f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_577643671ef7c85d4269132165b75455 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b8ec3efd41796b8de6576a1b64362b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d37c64f5d1535241cf5b452f297563cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6323-9540 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9fee4826390aa5a8054673ea45d2f55
date	2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7713301 https://doi.org/10.1038/s41598-020-78320-3 https://pubmed.ncbi.nlm.nih.gov/33273652
isPartOf	https://portal.issn.org/resource/ISSN/2045-2322 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39356
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer
discusses	http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0028388
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5b140c44abf169730a490c0db493eae0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16653 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21813 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19213

Total number of triples: 55.